Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 145 citing articles:

Deep generative molecular design reshapes drug discovery
Xiangxiang Zeng, Fei Wang, Yuan Luo, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100794-100794
Open Access | Times Cited: 143
A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 1, pp. 128-139
Open Access | Times Cited: 129
Deep learning for drug repurposing: Methods, databases, and applications
Xiaoqin Pan, Xuan Lin, Dongsheng Cao, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 98
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Jiansong Fang, Pengyue Zhang, Quan Wang, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 82
Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease
Matthew Adesuyan, Yogini Jani, Dana Alsugeir, et al.
Neurology (2024) Vol. 102, Iss. 4
Open Access | Times Cited: 22
Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease
Feixiong Cheng, Fei Wang, Jian Tang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101379-101379
Open Access | Times Cited: 20
Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
Benjamin R. Underwood, Ilianna Lourida, Jessica Gong, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders
Arun Samidurai, Lei Xi, Anindita Das, et al.
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 585-615
Open Access | Times Cited: 64
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease
Jielin Xu, Chengsheng Mao, Yuan Hou, et al.
Cell Reports (2022) Vol. 41, Iss. 9, pp. 111717-111717
Open Access | Times Cited: 58
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators
Pedrum Mohammadi‐Shemirani, Tushar Sood, Guillaume Paré
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 2, pp. 55-65
Open Access | Times Cited: 30
AD-BERT: Using pre-trained language model to predict the progression from mild cognitive impairment to Alzheimer's disease
Chengsheng Mao, Jie Xu, Luke V. Rasmussen, et al.
Journal of Biomedical Informatics (2023) Vol. 144, pp. 104442-104442
Open Access | Times Cited: 25
Drug repurposing for Alzheimer’s disease from 2012–2022—a 10-year literature review
Monika E. Grabowska, Annabelle Huang, Zhexing Wen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data
Chengxi Zang, Hao Zhang, Jie Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Artificial intelligence for drug discovery and development in Alzheimer's disease
Yunguang Qiu, Feixiong Cheng
Current Opinion in Structural Biology (2024) Vol. 85, pp. 102776-102776
Open Access | Times Cited: 14
Computational drug repurposing based on electronic health records: a scoping review
Nansu Zong, Andrew Wen, Sungrim Moon, et al.
npj Digital Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 35
Bringing machine learning to research on intellectual and developmental disabilities: taking inspiration from neurological diseases
Chirag Gupta, Pramod Chandrashekar, Ting Jin, et al.
Journal of Neurodevelopmental Disorders (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 33
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation
Jessica C. Lal, Chengsheng Mao, Yadi Zhou, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100749-100749
Open Access | Times Cited: 33
Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data
Chang Su, Yu Hou, Jielin Xu, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8
Protein Misfolding in Pregnancy: Current Insights, Potential Mechanisms, and Implications for the Pathogenesis of Preeclampsia
Bani Medegan Fagla, Irina A. Buhimschi
Molecules (2024) Vol. 29, Iss. 3, pp. 610-610
Open Access | Times Cited: 7
Network medicine‐based analysis of the hepatoprotective effects of Amomum villosum Lour. on alcoholic liver disease in rats
Wei Jing, Sihua Wang, Junze Huang, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 5, pp. 3759-3773
Open Access | Times Cited: 7
Sildenafil as a Candidate Drug for Alzheimer’s Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons
Dhruv Gohel, Pengyue Zhang, Amit Gupta, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 2, pp. 643-657
Open Access | Times Cited: 7
Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial
Alastair J.S. Webb, Jacqueline Birks, Karolina A. Feakins, et al.
Circulation Research (2024) Vol. 135, Iss. 2, pp. 320-331
Open Access | Times Cited: 7
DrugMAP 2.0: molecular atlas and pharma-information of all drugs
Fengcheng Li, Minjie Mou, LI Xiao-yi, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1372-D1382
Open Access | Times Cited: 6
The Alzheimer's Cell Atlas (TACA): A single‐cell molecular map for translational therapeutics accelerator in Alzheimer's disease
Yadi Zhou, Jielin Xu, Yuan Hou, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer's disease
Maria Rosaria Tropea, Walter Gulisano, Valeria Vacanti, et al.
Free Radical Biology and Medicine (2022) Vol. 193, pp. 657-668
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top